Back
Gilead Sciences, Inc. 10K Form
Buy
62
GILD
Gilead Sciences, Inc.
Last Price:
$155.00
Seasonality Move:
2.15%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2026-02-15 | 10K | GILD/Gilead Sciences, Inc. Annual |
| 2026-01-15 | 10K | GILD/Gilead Sciences, Inc. Annual |
| 2025-12-15 | 10K | GILD/Gilead Sciences, Inc. Annual |
| 2025-11-15 | 10K | GILD/Gilead Sciences, Inc. Annual |
| 2025-10-15 | 10K | GILD/Gilead Sciences, Inc. Annual |
| 2025-09-15 | 10K | GILD/Gilead Sciences, Inc. Annual |
Receive GILD News And Ratings
See the #1 stock for the next 7 days that we like better than GILD
GILD Financial Statistics
Sales & Book Value
| Annual Sales: | $29.4B |
|---|---|
| Cash Flow: | $3.3B |
| Price / Cash Flow: | 19.42 |
| Annual Sales: | $18.23 |
| Price / Book: | 8.5 |
Profitability
| EPS (TTM): | 6.78010 |
|---|---|
| Net Income (TTM): | $8.5B |
| Gross Margin: | $25.5B |
| Return on Equity: | 41.72% |
| Return on Assets: | 14.74% |
Gilead Sciences, Inc. Earnings Forecast
Key Gilead Sciences, Inc. Financial Ratios
-
The Gross Profit Margin over the past 35 years for GILD is 86.69%.
-
The Selling, General & Administrative Expenses for GILD have been equal to 0.00% of Gross Profit Margin.
-
The Research & Development expenses have been 19.32% of Revenue.
-
The Interest Expense is 12.03% of Operating Income.
-
The Net Earning history of GILD is 28.90% of Total Revenues.
-
Per Share Earnings over the last 35 years have been positive in 21 years.
Gilead Sciences, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | S&P500 |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | GILD |
| CUSIP: | 375558 |
| Website: | gilead.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 1.68 |
| Quick Ratio: | 1.31 |
Price-to-Earnings
| Trailing P/E Ratio: | 22.86 |
|---|---|
| Forward P/E Ratio: | 16.1 |
GILD Technical Analysis vs Fundamental Analysis
Buy
62
Gilead Sciences, Inc. (GILD)
is a Buy
Is Gilead Sciences, Inc. a Buy or a Sell?
-
Gilead Sciences, Inc. stock is rated a BuyThe current Gilead Sciences, Inc. [GILD] share price is $154.98. The Score for GILD is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.